CLOTTING FACTOR-VIII-IX-XI-XII DEFICIENT PLASMA— 510(k) K924396

Substantially Equivalent

Behring Diagnostics, Inc.

FDA 510(k) clearance K924396 for CLOTTING FACTOR-VIII-IX-XI-XII DEFICIENT PLASMA, Substantially Equivalent on 1993-05-21. Applicant: Behring Diagnostics, Inc..

Clearance details

Applicant
Behring Diagnostics, Inc.
Product code
Code GJT
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Somerville, NJ, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.